Annual CFF
$30.23 M
+$29.58 M+4565.12%
December 31, 2023
Summary
- As of February 7, 2025, CTMX annual cash flow from financing activities is $30.23 million, with the most recent change of +$29.58 million (+4565.12%) on December 31, 2023.
- During the last 3 years, CTMX annual CFF has risen by +$13.34 million (+78.95%).
- CTMX annual CFF is now -80.29% below its all-time high of $153.40 million, reached on December 31, 2015.
Performance
CTMX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$0.00
-$5.10 M-100.00%
September 30, 2024
Summary
- As of February 7, 2025, CTMX quarterly cash flow from financing activities is $0.00, with the most recent change of -$5.10 million (-100.00%) on September 30, 2024.
- Over the past year, CTMX quarterly CFF has dropped by -$29.67 million (-100.00%).
- CTMX quarterly CFF is now -100.00% below its all-time high of $135.58 million, reached on September 30, 2018.
Performance
CTMX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$5.52 M
-$29.67 M-84.32%
September 30, 2024
Summary
- As of February 7, 2025, CTMX TTM cash flow from financing activities is $5.52 million, with the most recent change of -$29.67 million (-84.32%) on September 30, 2024.
- Over the past year, CTMX TTM CFF has dropped by -$24.66 million (-81.72%).
- CTMX TTM CFF is now -96.55% below its all-time high of $159.98 million, reached on September 30, 2018.
Performance
CTMX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
CTMX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +4565.1% | -100.0% | -81.7% |
| 3 y3 years | +79.0% | -100.0% | -81.7% |
| 5 y5 years | -78.3% | -100.0% | -81.7% |
CTMX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -72.6% | +4565.1% | -100.0% | at low | -95.0% | +988.2% |
| 5 y | 5-year | -72.6% | +4565.1% | -100.0% | at low | -95.5% | +988.2% |
| alltime | all time | -80.3% | +4565.1% | -100.0% | +100.0% | -96.5% | +988.2% |
CytomX Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $0.00(-100.0%) | $5.52 M(-84.3%) |
| Jun 2024 | - | $5.10 M(+2830.5%) | $35.19 M(+15.7%) |
| Mar 2024 | - | $174.00 K(-28.7%) | $30.40 M(+0.6%) |
| Dec 2023 | $30.23 M(+4565.1%) | $244.00 K(-99.2%) | $30.23 M(+0.2%) |
| Sep 2023 | - | $29.67 M(+9259.3%) | $30.18 M(+5851.9%) |
| Jun 2023 | - | $317.00 K(>+9900.0%) | $507.00 K(-20.9%) |
| Mar 2023 | - | $0.00(-100.0%) | $641.00 K(-1.1%) |
| Dec 2022 | $648.00 K(-99.4%) | $190.00 K(>+9900.0%) | $648.00 K(-43.2%) |
| Sep 2022 | - | $0.00(-100.0%) | $1.14 M(-8.4%) |
| Jun 2022 | - | $451.00 K(+6342.9%) | $1.25 M(-16.2%) |
| Mar 2022 | - | $7000.00(-99.0%) | $1.49 M(-98.7%) |
| Dec 2021 | $110.21 M(+552.4%) | $683.00 K(+556.7%) | $110.21 M(-10.1%) |
| Sep 2021 | - | $104.00 K(-84.9%) | $122.55 M(-0.1%) |
| Jun 2021 | - | $691.00 K(-99.4%) | $122.61 M(-0.7%) |
| Mar 2021 | - | $108.73 M(+735.1%) | $123.47 M(+630.9%) |
| Dec 2020 | $16.89 M(+938.3%) | $13.02 M(+7697.0%) | $16.89 M(+295.3%) |
| Sep 2020 | - | $167.00 K(-89.2%) | $4.27 M(+2.5%) |
| Jun 2020 | - | $1.55 M(-28.2%) | $4.17 M(+25.6%) |
| Mar 2020 | - | $2.16 M(+437.9%) | $3.32 M(+104.0%) |
| Dec 2019 | $1.63 M | $401.00 K(+536.5%) | $1.63 M(-16.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | $63.00 K(-91.0%) | $1.95 M(-98.6%) |
| Jun 2019 | - | $698.00 K(+50.1%) | $137.46 M(-0.0%) |
| Mar 2019 | - | $465.00 K(-35.8%) | $137.49 M(-1.5%) |
| Dec 2018 | $139.62 M(+486.8%) | $724.00 K(-99.5%) | $139.62 M(-12.7%) |
| Sep 2018 | - | $135.58 M(>+9900.0%) | $159.98 M(+525.8%) |
| Jun 2018 | - | $722.00 K(-72.3%) | $25.56 M(+0.2%) |
| Mar 2018 | - | $2.60 M(-87.7%) | $25.51 M(+7.2%) |
| Dec 2017 | $23.80 M(+2289.2%) | $21.08 M(+1717.2%) | $23.80 M(+639.5%) |
| Sep 2017 | - | $1.16 M(+74.2%) | $3.22 M(+39.4%) |
| Jun 2017 | - | $666.00 K(-25.3%) | $2.31 M(+24.7%) |
| Mar 2017 | - | $891.00 K(+77.8%) | $1.85 M(+85.8%) |
| Dec 2016 | $996.00 K(-99.4%) | $501.00 K(+99.6%) | $996.00 K(-98.8%) |
| Sep 2016 | - | $251.00 K(+20.7%) | $83.14 M(+4.3%) |
| Jun 2016 | - | $208.00 K(+477.8%) | $79.71 M(-47.8%) |
| Mar 2016 | - | $36.00 K(-100.0%) | $152.60 M(-0.5%) |
| Dec 2015 | $153.40 M(+500.3%) | $82.65 M(-2697.3%) | $153.40 M(+116.8%) |
| Sep 2015 | - | -$3.18 M(-104.4%) | $70.76 M(-4.3%) |
| Jun 2015 | - | $73.10 M(+8654.9%) | $73.94 M(+8754.9%) |
| Mar 2015 | - | $835.00 K | $835.00 K |
| Dec 2014 | $25.55 M(+847.5%) | - | - |
| Dec 2013 | $2.70 M | - | - |
FAQ
- What is CytomX Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for CytomX Therapeutics?
- What is CytomX Therapeutics annual CFF year-on-year change?
- What is CytomX Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for CytomX Therapeutics?
- What is CytomX Therapeutics quarterly CFF year-on-year change?
- What is CytomX Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for CytomX Therapeutics?
- What is CytomX Therapeutics TTM CFF year-on-year change?
What is CytomX Therapeutics annual cash flow from financing activities?
The current annual CFF of CTMX is $30.23 M
What is the all time high annual CFF for CytomX Therapeutics?
CytomX Therapeutics all-time high annual cash flow from financing activities is $153.40 M
What is CytomX Therapeutics annual CFF year-on-year change?
Over the past year, CTMX annual cash flow from financing activities has changed by +$29.58 M (+4565.12%)
What is CytomX Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of CTMX is $0.00
What is the all time high quarterly CFF for CytomX Therapeutics?
CytomX Therapeutics all-time high quarterly cash flow from financing activities is $135.58 M
What is CytomX Therapeutics quarterly CFF year-on-year change?
Over the past year, CTMX quarterly cash flow from financing activities has changed by -$29.67 M (-100.00%)
What is CytomX Therapeutics TTM cash flow from financing activities?
The current TTM CFF of CTMX is $5.52 M
What is the all time high TTM CFF for CytomX Therapeutics?
CytomX Therapeutics all-time high TTM cash flow from financing activities is $159.98 M
What is CytomX Therapeutics TTM CFF year-on-year change?
Over the past year, CTMX TTM cash flow from financing activities has changed by -$24.66 M (-81.72%)